Melanie Gloria insider trades: Immunovant (IMVT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Melanie reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | IMVT | ↓ Sell | 2,241 | $32.06 | $72K | Direct | Oct 9, 2026 (2d) |
| Aug 20, 2026 | IMVT | ↓ Sell | 3,056 | $44.16 | $135K | Direct | Aug 21, 2026 (1d) |
| Jul 8, 2026 | IMVT | ↓ Sell | 2,036 | $39.55 | $81K | Direct | Jul 10, 2026 (2d) |
| Jun 26, 2026 | IMVT | ↓ Sell | 17,714 | $38.31 | $679K | Direct | Jun 26, 2026 (0d) |
| May 20, 2026 | IMVT | ↓ Sell | 3,115 | $32.45 | $101K | Direct | May 22, 2026 (2d) |
| Apr 8, 2026 | IMVT | ↓ Sell | 8,722 | $24.83 | $217K | Direct | Apr 10, 2026 (2d) |
| Nov 20, 2025 | IMVT | ↓ Sell | 12,626 | $23.62 | $298K | Direct | Nov 21, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMVT insiders
Open-market trades in the last 12 months
About Melanie Gloria's insider trades
Melanie Gloria is Chief Operating Officer at Immunovant (IMVT). Since Nov 20, 2025, Melanie has reported no open-market purchases and 7 sales worth $1.6M on SEC Form 4. In the last 12 months: 7 sales ($1.6M).
Their filings also include grants and awards (7 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.